相关实验视频

Updated: Jan 17, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

在患有炎症性肠病的患者中,各种自身免疫性并发症的患病率

Bipneet Singh¹, Shivam Kalra², Tejasvini Khanna³

¹Henry Ford Jackson, 159, W Michigan Ave, Jackson, MI 49201, USA.

Epidemiologia (Basel, Switzerland)

|September 22, 2025

概括

患有炎症性肠病 (IBD) 的患者自身免疫性疾病的发病率更高. 某些自身免疫性疾病会增加IBD患者的死亡风险,而其他疾病则与较低的死亡率有关.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
流行病学流行病学

背景情况:

患有炎症性肠病 (IBD) 的患者面临其他自身免疫性疾病的风险增加.
共同的遗传,环境和免疫学因素可能是这种关联的基础.
关于IBD患者自身免疫性疾病的住院患病率及其对死亡率的影响的数据有限.

研究的目的:

调查IBD患者自身免疫性并发症的住院患病率.
为了确定与IBD相关的特定自身免疫性疾病.
检查这些自身免疫性疾病与IBD患者的住院死亡结果之间的关联.

主要方法:

使用国家住院样本 (NIS) 数据库从2016年到2020年.
采用国际疾病分类第10版,临床修改 (ICD-10-CM) 代码来识别IBD和自身免疫疾病患者.
进行了多变量逻辑回归分析,以评估自身免疫疾病和IBD之间的关联,以及它们对死亡率的影响.

主要成果:

这项研究分析了141,478,025名患者的大量队列.
确定了IBD和24种不同的自身免疫性疾病之间的显著关联.
发现多菌性炎,自身免疫血液溶解性贫血 (AIHA),免疫性血栓细胞减少 (ITP) 和血栓性微血管病变与增加住院死亡风险相关.

结论:

这项研究强调了在IBD患者中更频繁地观察到的特定自身免疫并发症.
多髓炎,AIHA,ITP和血栓性微血管病变与IBD患者的住院死亡率较高有关.
牛皮和甲状腺功能低下症与医院死亡率的降低有关,因此需要进一步调查潜在机制.

关键词:

这是自身免疫力.炎症性肠病是一种炎症性肠病.这是一种多质神经炎.牛皮是一种牛皮.类风湿病学类风湿病学

更多相关视频

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

相关概念视频

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...